FDA Reopens Comment Period for Metered Dose Inhaler and Dry Powder Inhaler Drug Products Guidance

Summary

The US Food and Drug Administration (FDA) is reopening the comment period for its draft guidance on quality considerations for metered dose inhaler and dry powder inhaler drug products, allowing interested persons more time to submit comments, following the initial publication in the Federal Register on April 19, 2018.